These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26426999)

  • 1. Multimodal endoscope can quantify wide-field fluorescence detection of Barrett's neoplasia.
    Joshi BP; Duan X; Kwon RS; Piraka C; Elmunzer BJ; Lu S; Rabinsky EF; Beer DG; Appelman HD; Owens SR; Kuick R; Doguchi N; Turgeon DK; Wang TD
    Endoscopy; 2016 Feb; 48(2):A1-A13. PubMed ID: 26426999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of confocal laser endomicroscopy for the detection of neoplasia in patients with Barrett's esophagus.
    Xiong YQ; Ma SJ; Zhou JH; Zhong XS; Chen Q
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1102-10. PubMed ID: 26676646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
    Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
    J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
    Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
    Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
    Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology.
    Chen Y; Aguirre AD; Hsiung PL; Desai S; Herz PR; Pedrosa M; Huang Q; Figueiredo M; Huang SW; Koski A; Schmitt JM; Fujimoto JG; Mashimo H
    Endoscopy; 2007 Jul; 39(7):599-605. PubMed ID: 17611914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
    Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
    Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Barrett's neoplasia with a near-infrared fluorescent heterodimeric peptide.
    Chen J; Jiang Y; Chang TS; Rubenstein JH; Kwon RS; Wamsteker EJ; Prabhu A; Zhao L; Appelman HD; Owens SR; Beer DG; Turgeon DK; Seibel EJ; Wang TD
    Endoscopy; 2022 Dec; 54(12):1198-1204. PubMed ID: 35299273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus.
    Waterhouse DJ; Januszewicz W; Ali S; Fitzgerald RC; di Pietro M; Bohndiek SE
    Cancer Res; 2021 Jun; 81(12):3415-3425. PubMed ID: 34039635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
    Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confocal laser endomicroscopy for in vivo diagnosis of Barrett's oesophagus and associated neoplasia: a pilot study conducted in a single Italian centre.
    Trovato C; Sonzogni A; Ravizza D; Fiori G; Tamayo D; De Roberto G; de Leone A; De Lisi S; Crosta C
    Dig Liver Dis; 2013 May; 45(5):396-402. PubMed ID: 23352281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of in vivo vital-dye fluorescence endoscopic imaging for the detection of Barrett's-associated neoplasia.
    Thekkek N; Lee MH; Polydorides AD; Rosen DG; Anandasabapathy S; Richards-Kortum R
    J Biomed Opt; 2015 May; 20(5):56002. PubMed ID: 25950645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.